Sempra (0L5A)
London Exchange · UK · prices in USD · close of 21 Oct 2026
Key indicators
| Last close | USD 83.32 |
|---|---|
| 52-week range | 76.20 – 101.72 |
| Return, 1 month / 3 months | +3.7% / −9.8% |
| Return, 1 year / 3 years | −6.3% / +33.9% |
| Trend | Below its 200-day average |
| RSI (14) | 60 |
| Volatility (1 year) | 18.9% |
| Worst drawdown (1 year) | -21.8% |
| Average daily value traded | 0.87M USD |
| Dividend yield | 3.1% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Sempra is an energy infrastructure company based in San Diego, California. It serves customers through regulated utilities that deliver natural gas and electricity to homes and businesses in Southern California, and through a separate infrastructure business that develops and operates facilities such as liquefied natural gas export terminals, pipelines and power generation. Its customers include residential and commercial energy users, industrial buyers and international purchasers of liquefied natural gas.
On this site Sempra appears as a stock on the London Exchange (UK), code 0L5A, with prices in US dollars (USD). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Sempra (0L5A) trades on the London Exchange in UK. It last closed at USD 83.32 on 21 October 2026.
Its price-based Market X-Ray is 51 out of 100 (a fair price profile), ranking 1,984 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 6.3% and over the last three months it fell 9.8%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 37 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -5.7% | ||
| From 52-week high | -15.4% | ||
| Momentum | 28 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -9.8% | ||
| 6-month return | -9.8% | ||
| 12-month return, skipping the last month | -9.6% | ||
| Stability (higher is calmer) | 78 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 18.9% | ||
| Worst drawdown, 1 year (smaller is calmer) | -21.8% | ||
| Liquidity | 51 · Fair | Moderate trading activity. | |
| Average daily value traded | 0.87M USD | ||
| Zero-volume days | 0.0% | ||
| Income | 79 · Strong | Dividend is high and has been paid regularly. | |
| Dividend yield | 3.1% | ||
| Years with dividends | 6 |
Strengths
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
- Income: Dividend is high and has been paid regularly.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
Returns
| 1 week | +2.0% |
|---|---|
| 1 month | +3.7% |
| 3 months | −9.8% |
| 6 months | −9.8% |
| 1 year | −6.3% |
| 3 years | +33.9% |
| 5 years | – |
Signals
| 50-day / 200-day average | 82.15 / 88.40 |
|---|---|
| Golden / death cross (60 days) | Death, 44 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 2.13 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 23 Sep 2026 | USD 0.6575 |
| 24 Jun 2026 | USD 0.6575 |
| 18 Mar 2026 | USD 0.6575 |
| 10 Dec 2025 | USD 0.6450 |
| 30 Sep 2025 | USD 0.6450 |
| 25 Jun 2025 | USD 0.6450 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.